Amundi’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$669K Buy
9,389
+5,042
+116% +$345K ﹤0.01% 1431
2025
Q4
$257K Sell
4,347
-2,279
-34% -$124K ﹤0.01% 1688
2025
Q3
$364K Buy
6,626
+302
+5% +$15.7K ﹤0.01% 1403
2025
Q2
$296K Sell
6,324
-9,030
-59% -$348K ﹤0.01% 1517
2025
Q1
$532K Sell
15,354
-4,522
-23% -$200K ﹤0.01% 1478
2024
Q4
$750K Buy
19,876
+13,097
+193% +$545K ﹤0.01% 1478
2024
Q3
$234K Buy
6,779
+1,363
+25% +$54.3K ﹤0.01% 1620
2024
Q2
$232K Buy
+5,416
New +$262K ﹤0.01% 1545

Other funds holding NGVT

Amundi's NGVT Position: Q1 2026 in Review

Amundi increased its Ingevity (NGVT) stake by 116% in Q1 2026, buying an estimated $345K and bringing the position to 9,389 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Amundi first reported a position in NGVT in Q2 2024 and has held it in 8 quarters since. The position peaked at $750K in Q4 2024. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Amundi held 9,389 shares of Ingevity worth $669K as of Q1 2026.
  • Amundi bought 5,042 Ingevity shares in Q1 2026, an estimated $345K.
  • Ingevity made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1431 holding.
  • Amundi first reported a position in Ingevity in Q2 2024 and has held it in 8 quarters since.
  • Amundi's Ingevity position peaked at $750K in Q4 2024.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.